Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Journal of Medicinal Chemistry|January 31, 2009
Reactions of functionalized sulfonamides: application to lowering the lipophilicity of cytosolic phospholipase A2alpha inhibitorsLihren Chen, Weiheng Wang, Katherine L Lee, et al.
The Journal of Investigative Dermatology|January 24, 2020
Molecular and Cellular Responses to the TYK2/JAK1 Inhibitor PF-06700841 Reveal Reduction of Skin Inflammation in Plaque PsoriasisKaren M Page, Mayte Suarez-Farinas, Maria Suprun, et al.
The Journal of Biological Chemistry|September 13, 2007
Pharmacologic inhibition of tpl2 blocks inflammatory responses in primary human monocytes, synoviocytes, and bloodJ Perry Hall, Yahya Kurdi, Sang Hsu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 13, 2011
Cytosolic phospholipase A2α blockade abrogates disease during the tissue-damage effector phase of experimental autoimmune encephalomyelitis by its action on APCsParesh Thakker, Suzana Marusic, Nancy L Stedman, et al.
Scientific Reports|June 4, 2020
Demonstration of In Vitro to In Vivo Translation of a TYK2 Inhibitor That Shows Cross Species Potency DifferencesBrian S Gerstenberger, Mary Ellen Banker, James D Clark, et al.
The Journal of Allergy and Clinical Immunology|April 10, 2016
Tofacitinib attenuates pathologic immune pathways in patients with psoriasis: A randomized phase 2 studyJames Krueger, James D Clark, Mayte Suárez-Fariñas, et al.
The Journal of Experimental Medicine|September 21, 2005
Cytosolic phospholipase A2 alpha-deficient mice are resistant to experimental autoimmune encephalomyelitisSuzana Marusic, Michael W Leach, Jeffrey W Pelker, et al.
Journal of Medicinal Chemistry|January 6, 2006
Inhibition of cytosolic phospholipase A2alpha: hit to lead optimizationJohn C McKew, Megan A Foley, Paresh Thakker, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 14, 2011
Preclinical evaluation of an inhibitor of cytosolic phospholipase A2α for the treatment of asthmaChristopher A Hewson, Sheena Patel, Luigino Calzetta, et al.
Journal of Neuroimmunology|October 3, 2008
Blockade of cytosolic phospholipase A2 alpha prevents experimental autoimmune encephalomyelitis and diminishes development of Th1 and Th17 responsesSuzana Marusic, Paresh Thakker, Jeffrey W Pelker, et al.
Pageof 5